#1 Clinical Trials Search in Europe

Prednisolone Sodium Phosphate

This article examines clinical trials investigating the use of Prednisolone Sodium Phosphate, a corticosteroid medication, in treating different medical conditions. The trials cover a range of applications, including asthma exacerbations in children, multiple sclerosis, pneumonia, and uveitis. These studies aim to evaluate the efficacy, safety, and optimal dosing of Prednisolone Sodium Phosphate compared to other treatments or placebo.

Table of Contents

What is Prednisolone Sodium Phosphate?

Prednisolone Sodium Phosphate is a type of medication known as a corticosteroid. Corticosteroids are synthetic drugs that mimic the effects of hormones naturally produced by your adrenal glands. They are powerful anti-inflammatory agents, which means they help reduce swelling and inflammation in the body[1].

This medication is also known by other names, including:

  • Prednisolone
  • Prednesol

These alternative names may be used interchangeably by healthcare providers or on medication labels[2].

Medical Uses

Prednisolone Sodium Phosphate is used to treat a variety of conditions characterized by inflammation or overactivity of the immune system. Based on the clinical trials reviewed, it’s commonly used for:

  1. Asthma: It’s used to treat acute exacerbations (sudden worsening) of asthma in both adults and children. In some cases, it may be prescribed as a daily medication for severe asthma[3][2].
  2. Multiple Sclerosis (MS): Prednisolone is used to treat acute exacerbations of relapsing-remitting multiple sclerosis. MS is a condition where the immune system mistakenly attacks the protective covering of nerves[4].
  3. Pneumonia: Some studies are investigating its use in severe community-acquired pneumonia, which is a serious lung infection[5].
  4. B-cell Lymphomas: This is a type of cancer affecting white blood cells. Prednisolone is sometimes used as part of the treatment regimen[6].

How It’s Administered

Prednisolone Sodium Phosphate can be administered in several ways, depending on the condition being treated and the patient’s needs:

  • Oral tablets or liquid: Often prescribed for daily use in conditions like severe asthma[2].
  • Intravenous (IV) infusion: Used in hospital settings for acute conditions or when higher doses are needed[4].
  • Liposomal formulation: This is a newer form of the medication being studied, where the drug is encased in tiny fat bubbles. This may allow for more targeted delivery and potentially fewer side effects[7].

The dosage and duration of treatment can vary widely depending on the condition being treated and the individual patient’s response.

Effectiveness

Prednisolone Sodium Phosphate has been shown to be effective in several conditions:

  • Asthma: It can significantly reduce inflammation in the airways, helping to relieve symptoms like wheezing and shortness of breath[3].
  • Multiple Sclerosis: It can help shorten the duration of MS relapses and may reduce the severity of symptoms[4].
  • Pneumonia: Some studies suggest it may help reduce mortality (death rates) in severe cases of pneumonia, though more research is needed[5].

However, it’s important to note that the effectiveness can vary from person to person, and your doctor will monitor your response to the medication closely.

Potential Side Effects

Like all medications, Prednisolone Sodium Phosphate can cause side effects. Some potential side effects include:

  • Increased blood sugar levels (which can be a concern for people with diabetes)
  • Changes in mood or behavior
  • Increased appetite and weight gain
  • Fluid retention
  • Increased risk of infections

Long-term use of high doses may lead to more serious side effects, such as osteoporosis (weakening of bones), cataracts, or adrenal suppression (where your body stops producing its own cortisol)[2].

It’s crucial to discuss potential side effects with your healthcare provider and report any unusual symptoms you experience while taking this medication.

Ongoing Research

Researchers are continually studying Prednisolone Sodium Phosphate to understand its effects better and explore new potential uses:

  • Vascular Access for Dialysis: A study is investigating whether liposomal prednisolone can help improve the maturation of fistulas (surgically created blood vessel connections) used for hemodialysis in patients with kidney failure[7].
  • Comparison with Other Steroids: Some studies are comparing prednisolone to other corticosteroids like dexamethasone to determine which might be more effective or have fewer side effects in certain conditions[1].
  • New Formulations: Researchers are exploring new ways to deliver prednisolone, such as the liposomal formulation mentioned earlier, which might offer benefits over traditional forms of the medication[7].

These ongoing studies may lead to new uses for prednisolone or improvements in how it’s administered in the future.

Trial Focus Condition Prednisolone Sodium Phosphate Use Key Outcomes Measured
Asthma in Children Acute Exacerbations of Asthma Oral suspension, 1 mg/kg/day for 3 days PRAM score, relapse rate, compliance
Multiple Sclerosis Acute Exacerbation of MS Intravenous PEG-liposomal form, single 300 mg dose Changes in gadolinium-enhanced T1-weighted lesions
Pneumonia Community-acquired Pneumonia Not directly used (methylprednisolone compared) In-hospital mortality, ICU admission, length of stay
Uveitis Non-infectious Anterior Uveitis Topical eye drops, various concentrations Anterior chamber cell grade, visual acuity
Hemodialysis Fistula Arteriovenous Fistula Maturation Intravenous PEG-liposomal form, two 150 mg doses Cephalic vein diameter, radial artery flow

FAQ

  • What is Prednisolone Sodium Phosphate? Prednisolone Sodium Phosphate is a corticosteroid medication used to reduce inflammation in various medical conditions. It is a water-soluble form of prednisolone that can be administered orally or intravenously.
  • What medical conditions are being studied with Prednisolone Sodium Phosphate in these clinical trials? The clinical trials are investigating Prednisolone Sodium Phosphate for conditions such as asthma exacerbations in children, multiple sclerosis, pneumonia, anterior uveitis, and arteriovenous fistula maturation in hemodialysis patients.
  • How is Prednisolone Sodium Phosphate administered in these trials? Depending on the trial, Prednisolone Sodium Phosphate is administered in various forms, including oral tablets, oral suspension, intravenous infusion, and as part of a liposomal formulation.
  • What are some of the potential benefits of using Prednisolone Sodium Phosphate? Potential benefits include reducing inflammation, improving symptoms in conditions like asthma and multiple sclerosis, promoting healing in eye infections, and potentially improving outcomes in pneumonia patients.
  • Are there any side effects or risks associated with Prednisolone Sodium Phosphate? While specific side effects are not detailed in the trial summaries, corticosteroids like Prednisolone Sodium Phosphate can have side effects such as increased blood sugar, weight gain, and immune system suppression. The trials are designed to monitor for adverse events and assess the safety of the medication.

Ongoing Clinical Trials on Prednisolone Sodium Phosphate

  • Study of XTMAB-16 and Prednisolone Sodium Phosphate for Patients with Pulmonary Sarcoidosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark Italy Poland Spain

  • Study on Oral Prednisolone and Sucrose for Treating Wheezing Caused by Rhinovirus in Children Under 2 Years Old

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Corticosteroid: A class of steroid hormones produced in the adrenal cortex or made synthetically. They are used to reduce inflammation in various medical conditions.
  • Exacerbation: A worsening of symptoms or an increase in severity of a disease or condition.
  • Anterior Uveitis: Inflammation of the front part of the eye, including the iris and ciliary body.
  • Arteriovenous Fistula (AVF): An abnormal connection between an artery and a vein, often surgically created for hemodialysis access in patients with kidney failure.
  • Liposomal: A drug delivery system where medication is encapsulated in tiny fat bubbles to improve its absorption and effectiveness.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug being tested.
  • Randomized Trial: A study where participants are randomly assigned to different treatment groups to compare outcomes.
  • Efficacy: The ability of a treatment to produce the desired result under ideal conditions.
  • Intravenous (IV): Administered directly into a vein.
  • Multiple Sclerosis (MS): A chronic disease affecting the central nervous system, causing various neurological symptoms.

References

  1. https://clinicaltrials.gov/study/NCT04765371
  2. https://clinicaltrials.gov/study/NCT01948401
  3. https://clinicaltrials.eu/trial/study-on-oral-prednisolone-and-sucrose-for-treating-wheezing-caused-by-rhinovirus-in-children-under-2-years-old/
  4. https://clinicaltrials.gov/study/NCT01039103
  5. https://clinicaltrials.gov/study/NCT04007328
  6. https://clinicaltrials.gov/study/NCT01068392
  7. https://clinicaltrials.gov/study/NCT02495662